Showing 51-60 of 806 results for "".
Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 5
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-5/32903/Host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, discuss getting clinicians out of the mindset of using traditional IL-17 and IL-23 blockers for generalized pustular psoriasis, understanding that it is a chronic disease that needs a chronic trPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 1
https://practicaldermatology.com/series/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-1/32757/In the first installment of a six-part series, host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, provide an overview of generalized pustular psoriasis, including the unique challenges it poses, triggers associated with it, and the importance ofDermWireTV: Opzelura for Vitiligo; Biosimilars Boom; Updates from BTL and Cynosure; DIS Launch
https://practicaldermatology.com/topics/psoriasis/dermwiretv-opzelura-for-vitiligo-biosimilars-boom-updates-from-btl-and-cynosure-dis-launch/20109/FDA has approved Opzelura (ruxolitinib cream 1.5%, Incyte) for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Analysts predict that use of biosimilars in the US is about to increase significantly as Humira (adalimumab, AbbVie) faces patent eInbound Marketing: Why You Need a Strategy
https://practicaldermatology.com/topics/practice-management/inbound-marketing/18782/Focus on cultivating interactive marketing messages to show your audience what your practice is all about and what value it offers your target audience. "In your face" marketing is a thing of the past. Learn three strategies for successful inbound marketing for a medical practice in this Ekwa.com EJournal Club: S. Aureus-Driven AD Exacerbation
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-s-aureus-driven-ad-exacerbation/32404/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses a recent Journal of Drugs in Dermatology article about the need for a novel treatment for S. aureus exacerbated atopic dermatitis with Adelaide Hebert, MD.Schachner LA, Andriessen A, Gonzalez ME, Lal K, Hebert AA, EThe Resurgence of Ablative Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-resurgence-of-ablative-devices/18620/E. Victor Ross, MD, talks to host Joel L. Cohen, MD about the resurgence of traditional ablative devices. Dr. Ross says he never abandoned full-face CO2 resurfacing, but explains the key is to titrate the settings down—doing confluent 100 percent coverage but low-depth one pass on the forehead and cJournal Club: A Comprehensive Update
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-a-comprehensive-update/32402/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the recent Lancet article "Atopic Dermatitis" with primary author Emma Guttman, MD, PhD. Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405(10478):583-596. doi: 10.1016/S0140-6736(24)0New in My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical/23943/Getting to the Root of ACD
https://practicaldermatology.com/topics/atopic-dermatitis/getting-to-the-root-of-acd/20356/A practical approach to dermatitis in young and old.Unpacking the Latest CMS Proposal
https://practicaldermatology.com/topics/practice-management/unpacking-the-latest-cms-proposal/20349/What might these changes mean for dermatologists?